2025-06-01
Vivodyne has raised $40 million in Series A funding led by @khoslaventures with participation from new investors Lingotto, Helena, Fortius Ventures and existing investors Kairos Ventures, CS Ventures, Bison Ventures and MBX Capital. We're scaling our AI and robotics-powered [image]
Axios
Vivodyne, which uses AI and robots to grow human tissues in the lab for drug discovery and development, raised a $40M Series A led by Khosla Ventures
Katherine Davis / Axios :
2025-05-31
Vivodyne has raised $40 million in Series A funding led by @khoslaventures with participation from new investors Lingotto, Helena, Fortius Ventures and existing investors Kairos Ventures, CS Ventures, Bison Ventures and MBX Capital. We're scaling our AI and robotics-powered [image]
Axios
Vivodyne, which uses AI and robots to grow human tissues in the lab for drug discovery and development, raised a $40M Series A led by Khosla Ventures
Vivodyne, a San Francisco-based startup using lab-grown human tissues to discover and develop drugs, raised $40 million in a Series A led by Khosla Ventures.